GLP-1 medications like Ozempic and Mounjaro rose to fame for their ability to treat Type 2 diabetes, but their weight loss potential is what really skyrocketed their popularity
As of January 2026, the FDA has not approved tirzepatide in any oral form, including a pill, tablet, capsule, dissolvable oral product, sublingual product, or oral drops
In a study involving overweight individuals, it was demonstrated that those taking CLA showed significant fat loss compared to a placebo group
In Korea, where a considerable number of similar products have been launched under the influence of the "healthy pleasure" trend, the related market is expected to expand going forward
Practical implication: the proposed rule closes one major access pathway (503B industrial-scale compounding) while leaving the other (503A patient-specific compounding) operational under separate regulatory standards
Schedule Regular Appointments: Maintain regular check-ins with your doctor to monitor your progress and discuss any questions or concerns you may have